As if nosy reporters and complaining investors weren't enough, federal regulators may now be studying Steve Jobs's illness. More specifically, the SEC is reportedly looking into what and when the company knew about Jobs's still undisclosed ailment.
Maybe it's worthwhile, considering Jobs appeared to reverse course within a couple of weeks. But I'll be more than surprised if anything comes of this.
Short of subpoenaing Jobs's doctors (can they?), the company's responsibility would depend on what the Apple CEO disclosed to the company and its board. And I've already discussed how we shouldn't expect him to disclose much, particularly amid what might be a shifting and elusive diagnosis.
Reader Comments